argenx (ADR)
Develops antibody medicines for severe autoimmune diseases around the VYVGART franchise.
$1,023.21
After-hours close−0.20 (−0.02%)
At close$1,023.41(−3.35%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 45.43%Insiders —
Shares outstanding 62.19M · Float —
Institutions13F, as of Jun 30, 2026
524 holders · 28.25M shares · 84 new positions · 267 increased · 164 reduced · 55 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| FMR LLC | 5.23M | 8.41% | +240.4K | Aug 13, 2026 |
| Price T Rowe Associates Inc /MD/ | 2.68M | 4.31% | −696.9K | Aug 14, 2026 |
| Jupiter Topco LLC | 2.47M | 3.98% | +2.47Mnew | Aug 14, 2026 |
| Capital World Investors | 2.20M | 3.54% | −56.4K | Aug 12, 2026 |
| Artisan Partners Limited Partnership | 1.51M | 2.43% | +40.8K | Aug 13, 2026 |
| Avoro Capital Advisors LLC | 1.00M | 1.61% | 0 | Aug 14, 2026 |
| Wellington Management Group LLP | 930.5K | 1.50% | −90.9K | Aug 14, 2026 |
| BlackRock, Inc. | 777.2K | 1.25% | −31.1K | Aug 7, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| FMR LLC | 8.70% | 5.41M | 13G | May 6, 2026 ↗ |
| T. Rowe Price Associates, Inc. | 6.00% | 3.65M | 13G | Nov 14, 2025 ↗ |
InsidersForm 4
Latest trades
Nothing filed in the last 12 months.
CongressHouse and Senate disclosures
Not reported.